Clinical Trials
26 trialsNCT03581773 2026-05-04
DARENCA4
University of Aarhus
Phase 2 Recruiting
NCT04251949 2026-03-18
MuciLight
Centre Oscar Lambret
Phase 2 Completed
NCT06186700 2025-07-28
Effect of Pentoxifylline on Preventing Chemotherapy-induced Toxicities in Patients With Breast Cancer
Mansoura University
Phase 2 Completed
NCT04752384 2025-04-20
Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients
Medical College of Wisconsin
Phase 2 Completed
NCT03233776 2024-11-18
AFFECT-1
Radboud University Medical Center
Phase 2 Completed
NCT04099901 2024-11-18
AFFECT-2
Radboud University Medical Center
Phase 2 Completed
NCT04239261 2023-01-26
Serum-derived Bovine Immunoglobulin Effect on Mucositis
MercyOne Des Moines Medical Center
Phase 2 Terminated
NCT03101514 2021-06-23
Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study
First Affiliated Hospital of Harbin Medical University
Phase 2 Completed
NCT03955224 2021-04-08
ESMULLLAT
Institut Claudius Regaud
Phase 2 Withdrawn
NCT02058849 2019-08-14
Randomized Study of Beet Root in Locally Advanced Squamous Cell Cancer of the Head and Neck
University of Kentucky
Phase 2 Completed
NCT02123511 2019-04-30
Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy
Mayo Clinic
Phase 2 Completed
NCT01653327 2018-09-28
Analgesic Effects of Topical Ketamine Mouthwash in Patients Receiving Chemoradiation or Radiotherapy for Head & Neck Cancer
Dartmouth-Hitchcock Medical Center
Phase 2 Completed
NCT00352118 2017-12-28
Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
Masonic Cancer Center, University of Minnesota
Phase 2 Terminated
NCT01762514 2017-07-13
A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens
Sun Yat-sen University
Phase 2 Unknown
NCT00503776 2017-06-20
Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia
Vanderbilt-Ingram Cancer Center
Phase 2 Terminated
NCT01898091 2017-03-06
OM
Medical University of South Carolina
Phase 2 Completed
NCT02273752 2017-02-03
Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer
Emory University
Phase 2 Terminated
NCT00095927 2017-01-04
Randomized Amifostine For SCCHN
Dana-Farber Cancer Institute
Phase 2 Completed
NCT02252926 2016-08-16
Local Anesthetic Treatment of Oral Pain in Patients With Mucositis
Hvidovre University Hospital
Phase 2 Completed
NCT00533078 2015-07-23
LUNCH1
Insel Gruppe AG, University Hospital Bern
Phase 2 Completed
NCT02022358 2015-06-04
Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?
University College, London
Phase 2 Terminated
NCT01682031 2014-08-22
Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy
Roswell Park Cancer Institute
Phase 2 Terminated
NCT00698204 2014-06-05
Cox-2 Inhibition in Radiation-induced Oral Mucositis
UConn Health
Phase 2 Completed
NCT01674374 2013-05-15
Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation Therapy
Roswell Park Cancer Institute
Phase 2 Withdrawn
NCT01375088 2012-11-22
Assessing the Preventing and Therapeutic Effect of Propolis in Radiotherapy Induced Mucositis of Head and Neck Cancers
Mashhad University of Medical Sciences
Phase 2 Completed
NCT00965172 2012-03-22
Caphosol in Sarcoma Patients With Mucositis
M.D. Anderson Cancer Center
Phase 2 Completed